The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro
VON BUBNOFF, N, GORANTLA, S. P, ENGH, R. A, OLIVEIRA, T. M, THÖNE, S, ABERG, E, PESCHEL, C, DUYSTER, J
Published in Oncogene (24.02.2011)
Published in Oncogene (24.02.2011)
Get full text
Journal Article
The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107
VON BUBNOFF, N, GORANTLA, S. H. P, KANCHA, R. K, LORDICK, F, PESCHEL, C, DUYSTER, J
Published in Leukemia (01.09.2005)
Published in Leukemia (01.09.2005)
Get full text
Journal Article